Abstract
Aim
Cardiovascular (CV) disease is the leading cause of death in hemodialysis (HD) patients, and approximately half of mortalities in HD patients are attributed to CV disease. Atherosclerosis is the most frequent cause of CV complications in patients with end-stage renal disease (ESRD). Based on recent studies, cathepsin D has been suggested as a potential marker of atherosclerosis, and we hypothesized that there is an association between serum concentration of cathepsin D and carotid intima-media thickness (CIMT) in hemodialysis patients.
Methods
Thirty-one hemodialysis patients (18 men and 13 women) were enrolled in this study. Serum levels of soluble cathepsin D were measured with an enzyme-linked immunosorbant assay (ELISA) kit. CIMT was determined in each patient.
Results
The data showed that there was a positive significant correlation between serum concentration of cathepsin D and CIMT by using Pearson correlation (P value <0.05).
Conclusion
Based on the results of this study, cathepsin D could be suggested to have a role in the development of atherosclerotic plaques.
Similar content being viewed by others
References
Bevc S, Hojs R, Ekart R et al (2006) Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors. Acta Dermatovenerol Alp Panonica Adriat 15(4):151–157
Tsushima M, Terayama Y, Momose A et al (2008) Progression of atherosclerosis in hemodialysis patients: effect of adiponectin on carotid intima media thickness. J Atheroscler Thromb 15(4):213–218
Kawagishi T, Nishizawa Y, Konishi T et al (1995) High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48(3):820–826
Lepedda AJ, Cigliano A, Cherchi GM et al (2008) A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 203:112–118
Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868–874
Lutgens E, van Suylen RJ, Faber BC et al (2003) Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol 23(12):2123–2130
Stoneman VE, Bennett MR (2004) Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond) 107(4):343–354
Duran MC, Martin-Ventura JL, Mohammed S et al (2007) Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur J Pharmacol 562(1–2):119–129
Mitra AK, Dhume AS, Agrawal DK (2004) “Vulnerable plaques”—ticking of the time bomb. Can J Physiol Pharmacol 82(10):860–871
Vivanco F, Martin-Ventura JL, Duran MC et al (2005) Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res 4(4):1181–1191
Barderas MG, Dardé VM, de la Cuesta F et al (2008) Proteomic analysis of circulating monocytes identifies cathepsin D as a potential novel plasma marker of acute coronary syndromes. Clin Med: Cardiol 2:191–200
Jormsjo S, Wuttge DM, Sirsjo A et al (2002) Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 161(3):939–945
Hakala JK, Oksjoki R, Laine P et al (2003) Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 23(8):1430–1436
Benes P, Vetvicka V, Fusek M (2008) Cathepsin D—many functions of one aspartic protease. Crit Rev Oncol Hematol 68(1):12–28
Liu J, Sukhova GK, Sun JS et al (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24(8):1359–1366
Lutgens SP, Cleutjens KB, Daemen MJ et al (2007) Cathepsin cysteine proteases in cardiovascular disease. Faseb J 21(12):3029–3041
Ward MR, Pasterkamp G, Yeung AC et al (2000) Arterial remodeling. Mechanisms and clinical implications. Circulation 102(10):1186–1191
Cooper JB (2002) Aspartic proteinases in disease: a structural perspective. Curr Drug Targets 3(2):155–173
Miller BF, Kothari HV (1969) Increased activity of lysosomal enzymes in human atherosclerotic aortas. Exp Mol Pathol 10(3):288–294
Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459–467
Simon A, Gariepy J, Chironi G et al (2002) Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 20(2):159–169
Aminbakhsh A, Mancini GB (1999) Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 22(4):149–157
Greenland P, Abrams J, Aurigemma GP et al (2000) Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101(1):E16–E22
Hellings WE, Peeters W, Moll FL et al (2007) From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends Cardiovasc Med 17(5):162–171
Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108(14):1664–1672
Delucchi A, Dinamarca H, Gainza H et al (2008) Carotid intima-media thickness as a cardiovascular risk marker in pediatric end-stage renal disease patients on dialysis and in renal transplantation. Transplant Proc 40(9):3244–3246
Li W, Yuan X (2006) Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis. Ann N Y Acad Sci 1030(1):427–433
Chen GC, Liu W, Duchateau P et al (1994) Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects. J Biol Chem 269(46):29121–29128
Strojan P, Budihna M, Smid L et al (1998) Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Cancer Lett 130(1–2):49–56
Anim JT, John B, Abdulsathar SS et al (2005) Relationship between the expression of various markers and prognostic factors in breast cancer. Acta Histochem 107(2):87–93
Takato T, Yamada N, Ashida T (2008) Effects of aging and sex on progression of carotid intima-media thickness: a retrospective 6-year follow-up study. Geriatr Gerontol Int 8(3):172–179
Fan AZ, Paul-Labrador M, Merz CN et al (2006) Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study. BMC Cardiovasc Disord 6:42
Acknowledgments
This study is part of a research thesis for a Pharm.D. degree at Mashhad University of Medical Sciences. The authors are thankful for the funding of this study by the Research Council of Mashhad University of Medical Sciences and to Dr Paul A. Jowsey from Newcastle University, UK for his kind assistance in linguistic revision of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moallem, S.A., Nazemian, F., Eliasi, S. et al. Correlation between cathepsin D serum concentration and carotid intima-media thickness in hemodialysis patients. Int Urol Nephrol 43, 841–848 (2011). https://doi.org/10.1007/s11255-010-9729-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-010-9729-4